CHICAGO, March 29, 2024 (Globe Newswire) — Pharmaceutical membrane filtration market According to the latest report published by MarketsandMarkets™, sales are estimated to be worth $10.6 billion in 2024 and are expected to reach $19.6 billion by 2029, growing at a CAGR of 13.1% from 2024 to 2029 . Stringent regulatory requirements, increasing R&D investments by top pharmaceutical companies, increasing preference of biopharmaceutical manufacturers and researchers towards the use of single-use technologies, etc. are factors contributing to the market growth. On the other hand, issues such as membrane fouling and the high capital investment required to set up new production facilities can limit small businesses' access to the market and hinder market growth.
Download overview diagram: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031
Membrane filtration of pharmaceuticals market range:
Report scope |
detail |
Market revenue in 2024 |
$10.6 billion |
Estimates until 2029 |
$19.6 billion |
growth rate |
Expected to grow at a CAGR of 13.1% |
Available market size |
2021–2029 |
Forecast period |
2024-2029 |
prediction unit |
Value (US$ billion) |
Report scope |
Revenue forecast, competitive environment, growth factors, trends |
Target segment |
Products, technologies, types, uses, business scale |
Target area |
North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
Report highlights |
Updated player financial information/product portfolio |
Key market opportunities |
Growth opportunities in emerging countries |
Key market drivers |
Increased adoption of single-use technologies |
On the basis of product, the pharmaceutical membrane filtration market is segmented into membrane filters, systems, and other products. The membrane filter segment dominated the market in 2023 due to high adoption and usage of membrane filters in various pharmaceutical applications. Additionally, the high purchase frequency of these filters compared to systems and other products contributes to their advantage.
Based on technology, the pharmaceutical membrane filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other technologies. Microfiltration has various advantages over other technologies, such as the use of microfiltration for the filtration of aqueous solutions. This technology is also used to remove natural and synthetic organic matter to reduce the possibility of fouling. These factors account for the highest share and growth rate of this segment in the global market.
Based on application, the pharmaceutical membrane filtration market is segmented into final product processing, feedstock filtration, cell separation, water purification, and air purification. In 2023, final product processing was the largest and fastest growing application segment in the global pharmaceutical membrane filtration market. Regulatory authorities such as the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines and standards on drug manufacturers to ensure the safety, quality, and effectiveness of their products. Compliance with these regulations requires the implementation of robust filtration processes to treat the final product, increasing the demand for advanced membrane filtration technologies.
Based on type, the pharmaceutical membrane filtration market is segmented into sterile filtration and non-sterile filtration. Sterile filtration technology is expected to dominate this market in 2023 due to various factors such as the rapid growth of biologics, the need for sterile filtration during liquid processing of biopharmaceuticals, and the advantages offered by sterile filtration compared to non-filtration. accounted for the largest market share. -Sterile filtration.
Based on operational scale, the pharmaceutical membrane filtration market is segmented into manufacturing scale, pilot scale, and R&D scale. The scale of operations in pharmaceutical filtration depends on the size of the filtration production plant. The amounts, limits, and quantities that determine size vary by industry. The manufacturing scale segment is the largest and fastest growing segment in the pharmaceutical membrane filtration market in 2023. Growth in this segment can be attributed to increased demand for pharmaceuticals, the burgeoning biopharmaceutical industry, and the need to cater to growing emerging markets. .
Based on region, the pharmaceutical membrane filtration market is segmented into six major regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America dominated the pharmaceutical membrane filtration market. Europe accounted for her second largest share, followed by Asia Pacific. Asia Pacific market is expected to exhibit the highest growth rate during the forecast period. Expanding pharmaceutical manufacturing capacity, increasing demand for specialty medicines, technological advances and innovations in membrane design are some of the factors contributing to the region's growth.
Purchase the Pharmaceutical Membrane Filtration Industry Report (502-page PDF with insightful charts, tables, and figures). https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=255408031
The key players in the Pharmaceutical Membrane Filtration market covered in the report are:
-
Merck KGaA (Germany)
-
Danaher Corporation (USA)
-
Sartorius AG (Germany)
-
Thermo Fisher Scientific (USA)
-
3M (USA)
-
Parker Hannifin (USA)
-
Repligen Inc. (USA)
-
Asahi Kasei Corporation (Japan)
-
Eaton Corporation plc (Ireland)
-
GEA Group (Germany)
-
Corning Corporation (USA)
-
Alfa Laval Corporate AB (Sweden)
-
Donaldson Company, Inc. (USA)
-
Saint-Gobain (France)
-
MANN+HUMMEL International GmbH & Co. KG (Germany)
-
Meissner Filtration Products, Inc. (USA)
-
Cole-Parmer Instrument Company, LLC (USA)
-
Upresion (France)
-
Cantel Medical Corp. (USA)
-
WL Gore & Associates Inc. (USA)
-
Membrane Solutions (USA)
-
Amazon Filters Ltd. (UK)
-
Toyo Roshi Co., Ltd. (Japan)
-
Polvair (UK)
-
Starrytech (USA)
-
Synder Filtration, Inc. (USA)
-
Graver Technologies, LLC (USA)
-
Koch Membrane Systems (USA)
-
Nupore Filtration Systems (India)
-
Coveter Filtration Equipment Co., Ltd. (China)
-
and above all
Request a free sample page: https://www.marketsandmarkets.com/requestsampleNew.asp?id=255408031
This report segments the Pharmaceutical Membrane Filtration market into following segments:
Pharmaceutical membrane filtration market, by product
-
membrane filter
-
Polyethersulfone (PES) membrane filter
-
Polyvinylidene difluoride (PVDF) membrane filter
-
nylon membrane filter
-
Polytetrafluoroethylene (PTFE) membrane filter
-
Mixed Cellulose Ester & Cellulose Acetate (MCE & CA) Membrane Filter
-
Polycarbonate Track Etched (PCTE) Membrane Filter
-
Other membrane filters (PP, PC, CN, gelatin, PETE, RC)
-
-
system
-
single use system
-
reusable system
-
-
Other products
Pharmaceutical membrane filtration market, by technology
-
precision filtration
-
ultrafiltration
-
nanofiltration
-
Other techniques
Pharmaceutical Membrane Filtration Market, By Application
-
Processing of final products
-
Active Pharmaceutical Ingredient (API) Filtration
-
Protein purification
-
Vaccines and antibody treatments
-
Formulation and filling solutions
-
virus clearance
-
-
Raw material filtration
-
Cell separation
-
water purification
-
air purification
Pharmaceutical Membrane Filtration Market, By Type
-
sterile filtration
-
non-sterile filtration
Pharmaceutical membrane filtration market, by business size
Pharmaceutical membrane filtration market, by region
-
North America
-
Europe
-
Germany
-
England
-
France
-
Italy
-
Spain
-
Rest of Europe (RoE)
-
-
Asia Pacific (APAC)
-
latin america
-
middle east
-
GCC
-
Saudi Arabia
-
United Arab Emirates
-
The rest of GCC
-
-
rest of the middle east
-
-
Africa
Get 10% free customization on this report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031
Key market players:
-
Filter manufacturers, vendors, and distributors
-
Academic and government research institutions
-
Pharmaceutical and biotech companies
-
life science companies
-
venture capitalists and investors
-
Government agency
-
Private investigation company
-
Contract research organization (CRO)
-
Contract Development and Manufacturing Organization (CDMO)
Report purpose:
-
Define, describe and forecast the global Pharmaceutical Membrane Filtration market on the basis of product, technology, type, application, business size and region
-
To provide detailed information about the key factors influencing the growth of the market (drivers, constraints, opportunities, challenges, etc.)
-
To strategically analyze the micro markets with respect to individual growth trends, future prospects, and contribution to the overall Pharmaceutical Membrane Filtration market.
-
To analyze opportunities in the market for stakeholders and provide details of the competitive environment for market leaders
-
Forecast market segment size for six major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
-
Strategically profile key players and comprehensively analyze their product portfolio, market position, and core competencies
-
To track and analyze competitive developments such as acquisitions, product launches, expansions, and research and development activities in the Pharmaceutical Membrane Filtration market.
Related reports:
Pharmaceutical filtration market
Sterile filtration market
Hollow fiber filtration market
Depth filtration market
Laboratory filtration market
Research insights: https://www.marketsandmarkets.com/ResearchInsight/pharmaceutical-membrane-filtration-market.asp
Content source: https://www.marketsandmarkets.com/PressReleases/pharmaceutical-membrane-filtration.asp
CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com